[go: up one dir, main page]

AR055005A1 - Imidazo-benzodiazepinas tetraciclicas, procedimiento de obtencion de los mismos medicamentos y su uso de los compuestos para su fabricacion - Google Patents

Imidazo-benzodiazepinas tetraciclicas, procedimiento de obtencion de los mismos medicamentos y su uso de los compuestos para su fabricacion

Info

Publication number
AR055005A1
AR055005A1 ARP050105181A ARP050105181A AR055005A1 AR 055005 A1 AR055005 A1 AR 055005A1 AR P050105181 A ARP050105181 A AR P050105181A AR P050105181 A ARP050105181 A AR P050105181A AR 055005 A1 AR055005 A1 AR 055005A1
Authority
AR
Argentina
Prior art keywords
substituted
lower alkyl
halogen
cycloalkyl
hydrogen
Prior art date
Application number
ARP050105181A
Other languages
English (en)
Inventor
Bernd Buettelmann
Henner Knust
Andrew William Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR055005A1 publication Critical patent/AR055005A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/55131,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/55171,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente se refiere derivados de imidazo-(1,5-a)(1,2,4)triazolo(1,5-d)(1,4)benzodiazepina sustituida de la formula (1), en la que: R1 es hidrogeno, halogeno, alquilo inferior, alquilo inferior sustituido por halogeno, alcoxi inferior, alcoxi inferior sustituido por halogeno, nitro, cicloalquilo, -O(CH2)mO(CH2)mOH o -C=C-R'; R2 es hidrogeno o metilo; R3 es alquilo inferior, alquilo inferior sustituido por halogeno, alquenilo inferior, alquenilo inferior sustituido por halogeno, alquinilo inferior, -(CH2)n-cicloalquilo, -(CR'R'')m-CH3, o es fenilo, sin sustituir o sustituido por halogeno, o es piridinilo o tienilo, sin sustituir o sustituidos por alquilo inferior, o es -(CH2)n-NH-cicloalquilo, (alquenilo inferior)-cicloalquilo, (alquinilo inferior)-(CR'R'')mOH, o es (alquilo inferior)-fenilo, en el que el anillo fenilo está sin sustituir o sustituido por halogeno, CF3, alquilo inferior o alcoxi inferior; R' es hidrogeno o alquilo inferior; R'' es hidrogeno, hidroxi o alquilo inferior; n es 0, 1 o 2; m es 1, 2 o 3; o es 1 o 2; y a sus sales de adicion de ácido farmacéuticamente aceptables. Se ha encontrado que los compuestos de este grupo presentan una gran afinidad y selectividad para los sitios de fijacion del receptor GABA A alfa5 y que pueden ser utiles como mejoradores cognitivos o para el tratamiento de trastornos cognitivos, tales como la enfermedad de Alzheimer.
ARP050105181A 2004-12-14 2005-12-12 Imidazo-benzodiazepinas tetraciclicas, procedimiento de obtencion de los mismos medicamentos y su uso de los compuestos para su fabricacion AR055005A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04106556 2004-12-14

Publications (1)

Publication Number Publication Date
AR055005A1 true AR055005A1 (es) 2007-08-01

Family

ID=36129290

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050105181A AR055005A1 (es) 2004-12-14 2005-12-12 Imidazo-benzodiazepinas tetraciclicas, procedimiento de obtencion de los mismos medicamentos y su uso de los compuestos para su fabricacion

Country Status (17)

Country Link
US (1) US7432256B2 (es)
EP (1) EP1828194B1 (es)
JP (1) JP4783380B2 (es)
KR (1) KR100923393B1 (es)
CN (1) CN101115756B (es)
AR (1) AR055005A1 (es)
AT (1) ATE396998T1 (es)
AU (1) AU2005315913B2 (es)
BR (1) BRPI0515800A (es)
CA (1) CA2590333C (es)
DE (1) DE602005007265D1 (es)
ES (1) ES2307230T3 (es)
MX (1) MX2007007115A (es)
PL (1) PL1828194T3 (es)
RU (1) RU2393161C2 (es)
TW (1) TW200631953A (es)
WO (1) WO2006063708A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008064318A2 (en) * 2006-11-22 2008-05-29 University Of Medicine And Dentistry Of New Jersey Peripheral opioid receptor active compounds
US10206921B2 (en) 2009-06-03 2019-02-19 The Regents Of The University Of California Methods and compositions for treating a subject for central nervous system (CNS) injury
CN101891706B (zh) * 2010-04-09 2013-05-29 复旦大学 3,4-二氢苯并[f][1,4]噻氮杂*类化合物或其盐及其药物用途
WO2011153377A2 (en) * 2010-06-03 2011-12-08 The Regents Of The University Of California Methods and compositions for treating a subject for central nervous system (cns) injury
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
MX381561B (es) * 2013-12-20 2025-03-12 Agenebio Inc Derivados de benzodiazepina, composiciones, y métodos para tratar el deterioro cognitivo.
CN113264939A (zh) * 2015-06-19 2021-08-17 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物、组合物和方法
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio, Inc. derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
EA202190076A1 (ru) 2018-06-19 2021-09-22 Эйджинбайо, Инк. Производные бензодиазепина, композиции и способы лечения когнитивных нарушений
EP4495119A4 (en) 2022-03-16 2025-06-25 Jiangsu Hengrui Pharmaceuticals Co., Ltd. FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD AND MEDICAL USE THEREOF

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
ZW985A1 (en) * 1984-01-19 1985-08-28 Hoffmann La Roche Imidazodiazepine derivatives
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (es) * 1991-06-17 1993-03-01 Hoffmann La Roche
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
BRPI0519991A2 (pt) * 2004-10-20 2009-04-07 Hoffmann La Roche derivados de imidazo-benzodiazepina

Also Published As

Publication number Publication date
EP1828194B1 (en) 2008-05-28
CN101115756B (zh) 2010-06-16
JP4783380B2 (ja) 2011-09-28
US7432256B2 (en) 2008-10-07
KR100923393B1 (ko) 2009-10-23
RU2007121767A (ru) 2009-01-27
WO2006063708A1 (en) 2006-06-22
BRPI0515800A (pt) 2008-08-05
KR20070089227A (ko) 2007-08-30
MX2007007115A (es) 2007-07-11
JP2008523125A (ja) 2008-07-03
ATE396998T1 (de) 2008-06-15
CN101115756A (zh) 2008-01-30
TW200631953A (en) 2006-09-16
AU2005315913A1 (en) 2006-06-22
CA2590333A1 (en) 2006-06-22
AU2005315913B2 (en) 2011-11-24
ES2307230T3 (es) 2008-11-16
EP1828194A1 (en) 2007-09-05
US20060128691A1 (en) 2006-06-15
CA2590333C (en) 2013-01-08
PL1828194T3 (pl) 2008-11-28
DE602005007265D1 (de) 2008-07-10
RU2393161C2 (ru) 2010-06-27

Similar Documents

Publication Publication Date Title
AR055005A1 (es) Imidazo-benzodiazepinas tetraciclicas, procedimiento de obtencion de los mismos medicamentos y su uso de los compuestos para su fabricacion
UY30408A1 (es) Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones
PE20091444A1 (es) Derivados de isoxazolo-pirazina
NO20072833L (no) Bi- og tricykliske substituterte fenylmetanoner som glycinetransportor I-(Glyt-1)-inhibitorer for behandling av Alzheimers sykdom
PE20020583A1 (es) Derivados de benzodiazepina como moduladores del receptor gaba a
CO6260069A2 (es) Tiazolopiridin-2-iloxi-fenil y tiazolopirazin-2-iloxi-fenil aminas como moduladores de la leucotrieno a4 hidrolasa
HRP20100516T1 (hr) Tiazolpirazolopirimidini kao antagonisti receptora crf1
PE20020721A1 (es) Derivados de quinuclidina como agentes antimuscarinicos m3
ECSP066520A (es) Derivados de dihidrobenzofuranilo alcanamina y métodos para su uso
AR033753A1 (es) Derivados de imidazo[1,5-a]pirimido[5,4-d]benzazepina
AR041302A1 (es) Compuestos de imidazopiridina como agonistas del receptor 5- ht4 y composiciones farmaceuticas que comprenden dichos compuestos
NO20071967L (no) Imidazo-benzodiazepinderivater
CL2012000516A1 (es) Compuestos derivados de 3-[4-(4-(fenil/piridin/ pirimidin)- piperazin -1-il)-butil]-2, 3-dihidro-4h-croman-4-ona, moduladores del receptor de dopamina d3; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de un desorden neurologico o psiquiatrico, disfuncion erectil o dependencia a drogas, entre otros.
ATE414703T1 (de) Isoxazolderivate als inverse gaba a alpha5 agonisten
TW201540716A (zh) 新穎的唏及1,1a,2,7b-四氫環丙烷[c]唏吡啶并吡化合物
RU2009103300A (ru) Производные 2-бензоилимидазопиридинов, их получение и их применение в терапии
BR112015006454A8 (pt) derivados de etinila como moduladores de atividade de receptor de mglur5
AR056103A1 (es) Compuestos de(piran-piperidinil)benzimidazol, composiciones farmaceuticas que los comprenden, proceso de preparacion y usos en el tratamiento de afecciones mediadas por agonistas del receptor muscarinico m1
PE20080941A1 (es) Compuestos triciclicos como agonistas del receptor de melatonina
AR051333A1 (es) Derivados de benzodiaepina sustituida por halogeno
DE602006014185D1 (de) 3-arylisoxazol-4-carbonylbenzofuranderivative
PH12016501481A1 (en) Ethynyl derivatives
JP2019536759A (ja) 置換された二環式ヘテロアリール系ニコチン性アセチルコリン受容体アロステリック調節剤
BR112019025866A2 (pt) compostos e composições para indução de condrogênese
BR112015009990A2 (pt) derivados de pirazina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal